KEXXTONE VETERINARY

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

MONENSIN AS SODIUM

Tillgänglig från:

EUROMAR LTD

Läkemedelsform:

CAPSULES

Sammansättning:

MONENSIN AS SODIUM 32.4 G

Administreringssätt:

INTRARUMINAL

Receptbelagda typ:

Required

Tillverkad av:

ARGENTA MANUFACTURING LIMITED, NEW ZEALAND

Terapeutiska indikationer:

For the reduction in the incidence of ketosis in the peri-parturient dairy cow/ heifer which is expected to develop ketosis.

Tillstånd datum:

2019-12-31

Produktens egenskaper

1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Kexxtone Veterinary
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Monensin 32.4 g (equivalent to 35.2 g monensin sodium)
Each intraruminal device contains 12 subunits each containing 2.7 g
monensin (equivalent to 2.9
g monensin sodium).
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Continuous-release intraruminal device.
A cylindrical orange polypropylene intraruminal device uniquely
identified with a number, fitted
with wings, consisting of a core which presents as a stack of 12
subunits.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (dairy cows and heifers)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the reduction in the incidence of ketosis in the peri-parturient
dairy cow/heifer which is
expected to develop ketosis.
4.3 CONTRAINDICATIONS
Do not use in animals weighing less than 300 kg bodyweight.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients listed in
section 6.1.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Identification of animals for treatment should be at veterinary
discretion. Risk factors may
include a history of energy-deficiency-related diseases, high body
condition score and parity.
In the event of early regurgitation, identify the animal by matching
the animal ID number with
the number on the intraruminal device and re-administer an undamaged
intraruminal device (See
section 4.5).
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Hold treated cattle in a confined area for 1 hour after administration
to observe for failure to
swallow or regurgitation. If this occurs re-administer the
intraruminal device if undamaged. If
damaged, administer a new intraruminal device. Recheck cattle for up
to 4 days after dosing to
observe for signs of an intraruminal device lodging in the oesophagus.
Signs of lodging may include bloat which may be followed by coughing,
drooling, inappetence
and unthriftiness.
Special precautions to be taken by the